Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B

被引:45
作者
Catania, MG
Mischel, PS
Vinters, HV
机构
[1] Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med, Sec Neuropathol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Med Ctr, Inst Brain Res, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Med Ctr, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Med Ctr, Inst Neuropsychiat, Los Angeles, CA 90095 USA
关键词
cdc2; CDK1; cell cycle; cyclin B; hamartin; tuberin; tuberous sclerosis;
D O I
10.1093/jnen/60.7.711
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tuberous sclerosis (TSC) is a multi-system disorder characterized by hamartomatous rumors and abnormal brain development, with multiple foci of disrupted neuronal migration and giant dysmorphic neurons within cortical tubers. TSC is associated with mutations in 2 genes. TSC1 and TSC2, which encode hamartin and tuberin, respectively. The functions of these proteins have yet to he determined. Recently. the Drosophila homologue of TSC2. gigas, has been shown to be required for the G2/M transition of the cell cycle. However. the mechanism of this action remains unknown. Because the cyclin-dependent kinase CDK1 forms a complex with cyclin B1 to trigger the G2/M transition. we hypothesized that tuberin interacts with CDK1 to regulate its activity. In the study reported in this paper, we have used co-immunoprecipitation and confocal microscopy to demonstrate that tuberin interacts with and co-localizes with CDK1 and its binding partner cyclin B1 in multiple cell types. We also demonstrate that hamartin interacts with CDK1 and cyclin B1. We further present evidence that tuberin interacts with the other regulatory subunit of CDK1. cyclin A. These findings suggest a direct role fur tuberin and hamartin in modulating the activity of CDK1 during G2 and the G2/M transition. This is the first description of a role fur both tuberin and hamartin in a common cellular function, providing a potential mechanism for the identical clinicopathologic manifestations that result when either of these proteins are inactivated.
引用
收藏
页码:711 / 723
页数:13
相关论文
共 39 条
  • [1] 9Q34 LOSS OF HETEROZYGOSITY IN A TUBEROUS SCLEROSIS ASTROCYTOMA SUGGESTS A GROWTH SUPPRESSOR-LIKE ACTIVITY ALSO FOR THE TSC1 GENE
    CARBONARA, C
    LONGA, L
    GROSSO, E
    BORRONE, C
    GARRE, MG
    BRISIGOTTI, M
    MIGONE, N
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (10) : 1829 - 1832
  • [2] Catania MG, 2000, J NEUROPATH EXP NEUR, V59, P435
  • [3] New developments in the neurobiology of the tuberous sclerosis complex
    Crino, PB
    Henske, EP
    [J]. NEUROLOGY, 1999, 53 (07) : 1384 - 1390
  • [4] EKER R, 1981, DIAGN HISTOPATHOL, V4, P99
  • [5] Gomez MR., 1999, TUBEROUS SCLEROSIS C
  • [6] THE TUBEROUS SCLEROSIS GENE ON CHROMOSOME 9Q34 ACTS AS A GROWTH SUPPRESSOR
    GREEN, AJ
    JOHNSON, PH
    YATES, JRW
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (10) : 1833 - 1834
  • [7] LOSS OF HETEROZYGOSITY ON CHROMOSOME 16P13.3 IN HAMARTOMAS FROM TUBEROUS SCLEROSIS PATIENTS
    GREEN, AJ
    SMITH, M
    YATES, JRW
    [J]. NATURE GENETICS, 1994, 6 (02) : 193 - 196
  • [8] HIROSE T, 1995, ACTA NEUROPATHOL, V90, P387
  • [9] Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle
    Ito, N
    Rubin, GM
    [J]. CELL, 1999, 96 (04) : 529 - 539
  • [10] Johnson MW, 1999, BRAIN PATHOL, V9, P45